← All diseases
Liver, kidneys and digestion
Primary biliary cholangitis
Do you want to receive a message when there is new research about Primary Biliary Cholangitis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll receive a message as soon as there is new research about Primary Biliary Cholangitis. View what Premium costs.
Publications and studies (1837)
- A Dual Time Window-driven Strategy to Optimize Primary Biliary Cholangitis Treatment via Alkaline Phosphatase Normalization. (2026/06/28) ♡
- Single-Port Robotic Liver Surgery: A Pilot Feasibility Study of a Standardized Surgical Approach. (2026/06/27) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update. (2026/06/27) ♡
- Prognostic nutritional index as a predictor of ursodeoxycholic acid response in primary biliary cholangitis: a retrospective study. (2026/06/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of FGF1 in Chronic Liver Diseases. (2026/06/24) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Metachronous cholangiocarcinoma following pancreaticoduodenectomy and the potential role of a migrated pancreaticojejunal stent: a case report and review of the literature. (2026/06/22) ♡
- [Dietary serine supplementation inhibits the hepatic macrophage AKT/mTOR pathway and improves primary biliary cholangitis]. (2026/06/20) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Glycine attenuates double-stranded RNA-induced autoimmune cholangitis and pancreatitis by modulating innate immune signaling in mice. (2026/06/19) ♡
- Effect of testosterone addition to nutrition and exercise on muscle mass in men with cirrhosis: the next trial. (2026/06/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current Treatment of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Comprehensive Review. (2026/06/19) ♡
- Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective. (2026/06/05) ♡
- Glasgow Prognostic Score Predicts Hepatic Recompensation in Decompensated Primary Biliary Cholangitis: A Multicenter Cohort Study. (2026/06/04) ♡
- Folate deficiency correlates with severity of primary biliary cholangitis via modulating key regulatory genes. (2026/06/03) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. One-year outcomes by index treatment in older patients with acute cholecystitis. Protocol of the international, prospective, observational GOLDENEYE study. (2026/06/01) ♡
- Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter study. (2026/06/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A French National Cohort Study Including 571 Patients. (2026/06/01) ♡
- Single-cell transcriptomics reveals the ameliorative effect of gastrodin on cholestatic liver fibrosis. (2026/06/01) ♡
- Longitudinal health-related quality of life and associated factors in autoimmune liver diseases. (2026/06/01) ♡
- OPTN/SRTR 2024 Annual Data Report: Liver. (2026/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Evaluation of Abnormal Liver Biochemical Test Results. (2026/06/01) ♡
- A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF. (2026/05/28) ♡
- Cholangiocyte RUNX1 Orchestrates Fibrogenic and Inflammatory Signaling to Drive Biliary Fibrosis. (2026/05/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Adjuvant therapeutic effects and mechanisms of Yinchenhao decoction in obstructive jaundice: a narrative review. (2026/05/21) ♡
- Imperfect Maturation of Erythroid Progenitors in Patients with Cirrhosis-Associated Anemia. (2026/05/14) ♡
- ISG15 deficiency in hepatic stellate cells promotes TGFβ2-induced liver fibrosis by counteracting CREB1 ISGylation. (2026/05/12) ♡
- Expression characteristics of C-reactive protein in autoimmune diseases and their complications. (2026/05/11) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Recovery Kinetics and Persistent Hepatic Alterations in a Xenobiotic-induced Murine Model of Chronic Cholestatic Liver Disease. (2026/05/08) ♡
- Exploring the interaction between metabolic dysfunction and alcohol-associated hepatitis: A global study. (2026/05/06) ♡
- Clonorchis sinensis excretory secretory products promote hepatic fibrosis through stimulating biliary epithelium to secrete IL-17A. (2026/05/05) ♡
- Baseline oral microbiome associated with post-living donor liver transplant early complications within 6 months. (2026/05/01) ♡
- Organ-specific autoimmunity in primary Sjögren's disease. (2026/05/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Differences in immunosuppressive strategies for primary sclerosing cholangitis after liver transplantation. (2026/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Indian National Association for Study of the Liver Guidance Document on Difficult to Treat Autoimmune Hepatitis. (2026/05/01) ♡
- The Conjugated Bile Acids Profile Suggests a Novel Liver-Muscle Axis Associated With Sarcopenia in Chronic Liver Disease. (2026/05/01) ♡
- Pediatric MR cholangiopancreatography: comparison of 3D fast spin-echo and single-shot fast spin-echo thick-slab techniques for pancreaticobiliary anatomy. (2026/04/30) ♡
- Accurate detection of cholangiocarcinoma in primary sclerosing cholangitis using DNA methylation biomarkers in bile and plasma. (2026/04/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Primary sclerosing cholangitis. (2026/04/18) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies. (2026/04/13) ♡
- Primary Biliary Cholangitis Presenting with Low Back Pain and Complicated by Immune-Mediated Necrotizing Myositis: A Case Report. (2026/04/07) ♡
- Clinical Impact of Recurrence Beyond the Milan Criteria After Curative Resection of Hepatocellular Carcinoma. (2026/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated Cirrhosis. (2026/04/01) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. Spanish clinical practice guidelines for the diagnosis and management of cholestatic liver diseases in adult and pediatric population: Joint report from AEEH and SEGHNP. (2026/04/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Self-expandable metal stents versus plastic stents for unresectable malignant hilar biliary obstruction: A systematic review and meta-analysis of reconstructed individual patient data from randomized controlled trials with meta-regression. (2026/04/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Serum predictors of native liver survival post-Kasai: Systematic review and meta-analysis. (2026/04/01) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statement. (2026/04/01) ♡
- Defining the Contribution of Genetic Variants in MRGPRX4 With Pruritus in Paediatric Cholestasis: Evidence From Case-Control Study. (2026/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Zoledronic acid improves bone mineral density at the lumbar spine and total hip in adults with chronic liver disease. (2026/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Should nasogastric enteral feeding become a standard escalation to reverse malnutrition in liver transplant candidates? (2026/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. [Hepatic Overlap Syndrome: Primary Sclerosing Cholangitis and Primary Biliary Cholangitis. Case Review]. (2026/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Double Filtration Plasmapheresis for Refractory Hypercholesterolemia in Drug-Induced Cholestasis: A Case Report. (2026/04/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.